SEC Filings | Zevra Therapeutics, Inc.

Filing date	Form	Description	Filing Group	View
04-05-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-009361.rtf 0001437749-23-009361.xls 0001437749-23-009361.pdf View HTML
04-03-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-009080.rtf 0001437749-23-009080.xls 0001437749-23-009080.pdf View HTML
03-30-2023	8-K	Report of unscheduled material events or corporate event	Current Reports	0001437749-23-008527.rtf 0001437749-23-008527.xls 0001437749-23-008527.pdf EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
03-30-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-008650.rtf 0001437749-23-008650.xls 0001437749-23-008650.pdf View HTML
03-29-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-008405.rtf 0001437749-23-008405.xls 0001437749-23-008405.pdf View HTML
03-29-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-008416.rtf 0001437749-23-008416.xls 0001437749-23-008416.pdf View HTML
03-29-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-008434.rtf 0001437749-23-008434.xls 0001437749-23-008434.pdf View HTML
03-21-2023	4	Statement of changes in beneficial ownership of securities	3,4,5	0001437749-23-007397.rtf 0001437749-23-007397.xls 0001437749-23-007397.pdf View HTML
03-17-2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	0001437749-23-006961.rtf 0001437749-23-006961.xls 0001437749-23-006961.pdf View HTML
03-17-2023	DEFC14A	Definitive proxy statement in connection with contested solicitations	Proxy Filings	0001477932-23-001547.rtf 0001477932-23-001547.xls 0001477932-23-001547.pdf View HTML

Filing Group

View

04-05-2023